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Simar J. Singh1, William Turner2, Drew E. Glaser2, Kara E. McCloskey2 and Fabian V. Filipp1*Abstract
Background: Vascular progenitor cells (VPCs) derived from embryonic stem cells (ESCs) are a valuable source for
cell- and tissue-based therapeutic strategies. During the optimization of endothelial cell (EC) inductions from mouse
ESCs using our staged and chemically-defined induction methods, we found that cell seeding density but not VEGF
treatment between 10 ng/mL and 40 ng/mL was a significant variable directing ESCs into FLK1+ VPCs during stage 1
induction. Here, we examine potential contributions from cell-to-cell signaling or cellular metabolism in the production
of VPCs from ESCs seeded at different cell densities.
Methods: Using 1D 1H-NMR spectroscopy, transcriptomic arrays, and flow cytometry, we observed that the
density-dependent differentiation of ESCs into FLK1+ VPCs positively correlated with a shift in metabolism and
cellular growth.
Results: Specifically, cell differentiation correlated with an earlier plateauing of exhaustive glycolysis, decreased lactate
production, lower metabolite consumption, decreased cellular proliferation and an increase in cell size. In contrast, cells
seeded at a lower density of 1,000 cells/cm2 exhibited increased rates of glycolysis, lactate secretion, metabolite
utilization, and proliferation over the same induction period. Gene expression analysis indicated that high cell seeding
density correlated with up-regulation of several genes including cell adhesion molecules of the notch family (NOTCH1
and NOTCH4) and cadherin family (CDH5) related to vascular development.
Conclusions: These results confirm that a distinct metabolic phenotype correlates with cell differentiation of VPCs.
Keywords: Stem cells, Differentiation, Vascular fate, Cell seeding density, Systems biology, Metabolism, NMR,
Metabolomics, Fluorescence-activated cell sorting, Flow cytometry, Cell adhesion, Cell contact, Cell communication,
Microenvironment, Cancer stem cells, Embryonic stem cells, Vascular progenitor cells, Endothelial cellsBackground
Vascular progenitor cells (VPCs) and endothelial cells
(ECs) are desirable cell sources for cellular therapeutic
and tissue engineering strategies including: peripheral
vascular disease [1, 2], severe ischemic heart disease
[3, 4] and lining the lumens of small diameter vascular
grafts in order to minimize thrombosis or arteriosclerosis
[5, 6]. In cancer, the vascular niche promotes cancer stem
cells (CSCs) and is enriched with CSC-derived ECs, which
promote tumor invasion and metastasis [7]. VPCs are
important for maintenance of the stemness of normal* Correspondence: filipp@ucmerced.edu
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(http://creativecommons.org/publicdomain/zeadult stem cells, including self-renewal, undifferenti-
ated status, and dormancy. However, it is sometimes
difficult to obtain sufficient numbers of proliferating
VPCs and ECs, especially from aged adults and
diseased patients [6]. Alternatively, embryonic stem
cells (ESCs) and induced pluripotent stem cells
(iPSCs) with their unlimited capacity for self-renewal,
are considered excellent cell sources in a variety of
cell-based therapies. In addition to their growing
therapeutic applications, these cell sources in combination
with derived VPCs and ECs can also serve as representa-
tive in vitro models of vascular development.
During early stages of vascular development, sig-
naling from vascular endothelial growth factor
(VEGF = VEGFA, vascular endothelial growth factorle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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(FLK1 = VEGFR = KDR, kinase insert domain recep-
tor, GeneBank: 3791) promotes ventral mesoderm
and hematopoietic fate [8–10] leading to activation
of the mitogen activated protein kinase pathway [11].
Endothelial, hematopoietic, and smooth muscle cells
have been derived from outgrowths of FLK1+ VPCs,
making this VEGF receptor a hallmark for identifica-
tion of VPCs [12]. However, despite our growing un-
derstanding of the critical biochemical factors in
development, the precise timing and quantitative levels
of EC induction/activation for directing vascular fate
from ESCs in vitro have remained confounding. This is
complicated by the inherent variability in kinetic and
autocrine signaling from ESC line-to-ESC line [13]. For
example, the optimal time to induce the mouse D3-ESC
line into FLK1+ VPCs has been reported to occur at
day 4 (FLK1+ = FLK1 positive = VEGFR expressing cells)
[14–16], while the optimal time for the corresponding
mouse R1-ESC line has been reported at day 2 [17]. Add-
itionally, while VEGF is the most published growth factor
associated with directing EC differentiation, published
treatment levels vary between 20 ng/mL and 50 ng/mL
[12, 15, 18]. Matrix signaling is also an important signal in
stem cell fate, but studies on this topic have also been con-
flicting. For example, it has been reported that collagen
type-IV directs a higher percentage of ECs [12, 15, 18].
However, more recent studies show fibronectin pro-
motes increased cell adhesion and/or proliferation, gener-
ating greater numbers of VPCs and ECs compared with
collagen-type IV [1, 17]. Moreover, increasing evidenceFig. 1 Higher seeding density yields higher expression of differentiation m
receptor). Schematic of staged differentiation of embryonic stem cells (ESC
representative micrographs from A3-ESCs seeded at 10,000 cells/cm2. Stage
BMP4 (bone morphogenetic protein 4) and VEGF (vascular endothelial grow
for FLK1 receptor expression by an anti-FLK1 antibodysupports a role for modified cellular metabolism in the
regulation of stem cell self-renewal, specification, and
plasticity in cancer and development [19–21]. Despite
this growing understanding of cellular metabolism as a
regulator of cell function, the role of cell seeding den-
sity in metabolic alterations supporting vascular fate is
not defined.
Therefore, using our established staged differentiation
methodology and chemically-defined media formulations
(Fig. 1a), we examined a number of combinatorial
variables (induction time, VEGF treatment, matrix
signaling, and cell seeding density) for directing the
generation of VPCs (stage 1). The results indicated that
cell seeding density was a significant factor in the first
stages of induction of ESCs into VPCs, especially in the
A3-ESC cell line [22] generated by our own laboratory.
Therefore, we set out to further examine the underlying
mechanisms related to density-dependent differentiation
in this ESC line.
Methods
Embryonic stem cell culture
Mouse A3-ESCs were extracted, generated, and cultured
at 3,000/cm2 on inactivated mouse embryonic fibroblasts
(MEFs; 20,000/cm2) [22]. Prior to induction, the A3-ESCs
are purified from MEFs by gravity separation followed by
MEF adhesion to tissue culture dishes for 1–2 hours and
passaged onto 0.5% gelatin-coated plates in ESC culture
media containing: Knockout Dulbecco’s Modified Eagle
Medium (KO-DMEM; Invitrogen), 15% Knockout Serum
Replacer (KSR; Invitrogen), 1Χ penicillin-streptomycinarker FLK1 (FLK1 = VEGFR = KDR, VEGF receptor, kinase insert domain
s) into vascular progenitor cells (VPCs) and endothelial cells (ECs) with
1 involves the culturing of ESCs on fibronectin in the presence of
th factor). At the completion of Stage 1, resulting VPCs are assayed
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2 mM L-glutamine (Invitrogen), 0.1 mM 2-mercaptoethanol
(Calbiochem), 2000 units/mL of leukemia inhibitory
factor (LIF-ESGRO; Chemicon), and 10 ng/mL of bone
morphogenetic protein 4 (BMP4, GeneBank: 652)
(R&D Systems). Full media changes occurred every other
day and cells were passaged every 4–5 days.
Induction of FLK1+ VPCs
A3-ESCs were harvested and plated at either 1,000,
5,000 or 10,000 cells/cm2 in 12-well cell culture dishes,
coated with 50 ng/mL fibronectin (BD Biosciences), and
fed our induction media: alpha-minimal essential medium
(MEM; Corning), 20% KSR (Invitrogen), 1Χ penicillin-
streptomycin (Invitrogen), 1Χ nonessential amino acids
(Invitrogen), 2 mM L-glutamine (Invitrogen), 0.05 mM
2-mercaptoethanol (Calbiochem), and 5 ng/mL BMP4
(R&D Systems), and 0 to 30 ng/mL of VEGF (R&D
Systems) without media change for 4 days. Experi-
ments were conducted in triplicate (N = 3) allowing for
analysis of variance. The assessment of stage 1 VPCs,
which are not contact-inhibited, was quantified by the
percentage of FLK1+ cells over time, previously shown
to correlate with down-regulation of the pluripotent stem
cell marker POU class 5 homeobox 1 (POU5F1 = OCT3/4,
GeneBank: 5460) over the same time period [22].
Characterization of VPCs
Adherent cells were harvested using Cell Dissociation
Buffer (Invitrogen), fixed in 4% paraformaldehyde
(Tousimis), rinsed 2Χ with phosphate buffered saline
(PBS), blocked using 0.5% donkey serum (Fitzgerald) and
1% bovine-serum albumin (Sigma) for 1 h at room
temperature, and stained with Alexa Fluor 647®-conju-
gated anti-FLK1 antibody (Biolegend) at 1:100 and allowed
to incubate overnight at 4 °C. Cells were rinsed 2Χ with
PBS before being analyzed on an LSR II flow cytometer
(BD Biosciences) and FloJo Software (TreeStar) at 1, 2,
and 3 days post induction of differentiation. Samples were
analyzed in triplicate (N = 3) for each data point.
Exometabolome analysis
Triplicate samples of conditioned induction media (N = 3)
were harvested at 1, 2 and 3 days post-induction and
stored at −80 °C. Prior to 1D 1H-NMR spectroscopy
metabolomics analysis, supernatants were extracted using
1:1 cold methanol (BDH 67-56-1) and chloroform
(Amresco 0757) mixture [7]. The extracts were cleared by
centrifugation at 14,000 g and the aqueous phase was
collected. Freeze-dried metabolite samples were resus-
pended in 200 μL of H20 with 5% D2O spiked with
0.75% 3-(trimethylsilyl)propanoic-2,2,3,3-d4 acid (TSP)
(Sigma 293040) to a final concentration of 2.409 mM
into 3 mm NMR tubes (Norrell C-S-3-HT-7). Spectrawere recorded using 1D 1H excitation sculpting at
512 scans, d1 = 1 s, 1H pulse 11.0 μs, power level of
shaped pulse 25.55db and an experimental time of
10 min at 300 K at an Avance II 600-MHz spectrometer
fitted with a cryogenic probe operating with TOPSPIN
2.0 (Bruker BioSpin GmbH). All spectra were automati-
cally phased, baseline corrected and referenced to TSP
(δ 0.00 ppm) using Chenomx NMR spectroscopy suite
8.1 (Chenomx Inc). Metabolite concentrations were
quantified on the basis of matching chemical shifts and
multiplicities to the Chenomx reference compound
library. Exometabolome analysis by NMR spectroscopy
provides direct comparison of absolute metabolite con-
centrations of analytes. Not surprisingly, the amount of
metabolites excreted or taken up scales with the initial
seeding density. Therefore, by normalizing each time
point to the first time point post-induction, dynamic infor-
mation of the system can be obtained. The total cell count
prior seeding was obtained in triplicate (N = 3) by analy-
zing cells accurately using multifocal plane analysis in
the TC20 automated cell counter (Biorad).
Cell size and proliferation
Cell diameter and proliferation rates were measured
over the 3 days of VPC induction using an automated
image-based cytometer. Cells were harvested using
0.25% trypsin-EDTA (Corning) from fibronectin
coated cultures dishes at 1, 2 and 3 days post induc-
tion of differentiation, stained with trypan blue, and
pipetted into disposable counting chambers for count-
ing and image analysis. Cell diameter measurements
of live differentiating ESCs were obtained in the TC20
automated cell counter (Biorad). Multi-planar bright-
field digital images were automatically collected,
quantified, and assessed for cell number and diameter.
Cell proliferation rates were calculated and densities
validated from the live cells per dish (N = 6) over the
3 days of VPC induction.
Differential gene expression
Total RNA was extracted from undifferentiated ESCs
as well as from cells 3 days post induction of differ-
entiation using TRIzol (Sigma T9424). At least three
biological replicates of RNA samples were analyzed per
condition. The concentration of RNA was determined
using a Nanodrop spectrophotometer (Thermo Scientific).
Two micrograms of RNA was processed with the RT2
profiler array PAMM-146Z (Qiagen SABiosciences) and
used to synthesize cDNA using the RT2 SYBR green master
mix (Qiagen SABiosciences) in a 7300 real-time (RT)
quantitative polymerase chain reaction (QPCR) System
(Applied Biosystems). Gene expression profiles were
analyzed using the ΔΔCT method. RT QPCR thresh-
old cycle (CT) values were normalized using five different
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60, B2M, beta-2-microglobulin, GeneBank: 567, GAPDH,
glyceraldehyde-3-phosphate dehydrogenase, GeneBank:
2597, GUSB, glucuronidase beta GeneBank: 2990, and
HSP90AB1, heat shock protein 90 kDa alpha family class B
member 1, GeneBank: 3326. The difference threshold cycle
value (ΔCT) of any gene of interest (GOI) to the average
housekeeping value was calculated using the formula
ΔCT(GOI) = CT(GOI) — AVERAGE(CT(HKG)) for ESCs,
differentiating cells at seeding density of 1,000 cells/cm2
and 10,000 cells/cm2. In addition, change in gene expres-
sions of any gene of interest was monitored by calculating
ΔΔCT(GOI) = ΔCT(GOI-10 K) — ΔCT(GOI-1 K).
RT2 gene array profiles were normalized, separated
according to differential expression between the two
seeding densities in univariate T-tests with a random
variance model using a p-value cut-off below 0.05, and
ranked with LOG2 fold-change of specimen seeded at
10,000 cells/cm2 in comparison to 1,000 cells/cm2 consi-
dered significant.
Differential protein expression analysis
Induced VPCs originally seeded as ESCs at 1,000 cells/cm2
or 10,000 cells/cm2 were harvested 3 days post induction.
Cells were fixed, washed, and blocked in PBS supple-
mented with 2% fetal bovine serum (FBS; Corning 35-010-
CV). Cells were incubated light-protected at 4 °C for 1 h
with the following antibodies and staining reagents: FLK1
PerCP (Biolegend 121915), CDH2 rabbit polyclonal
(Abcam ab12221), CDH5 (CD144) brilliant violet 421 (Bio-
legend 138013), and Fixable Viability Dye eFluor780
(eBioscience 65-0865-14). After washing, cells were incu-
bated light protected at 4 °C for 1 h with FITC conjugated
Donkey Anti-Rabbit IgG pre-adsorbed (Abcam ab7079).
Samples were rinsed twice with PBS supplemented with
2% FBS before being analyzed on an LSR II flow cyt-
ometer (BD Biosciences) at a flow rate at least 500
events per second. 100,000 events per sample were re-
corded and samples were analyzed in triplicate (N = 3)
for each data point. FloJo Software (TreeStar) was
used for data analysis. Dead cells were gated out from
analysis based on Viability Dye eFlour780 reactivity.
FLK1+ cells were then analyzed for FITC (CDH2) and
Brilliant Violet 421 (CDH5) fluorescence and the percent-
age of Flk1+/CDH2+CDH5+ cells were compared between
low density and high density groups.
Results
Characterization of differentiated FLK1+ VPCs
Induction of mouse A3-ESCs [22] into VPCs was exam-
ined over a range of seeding densities, VEGF treatment
levels, and time (Fig. 2a). The greatest number of FLK1+
cells was generated on day 3, with a reduction at day 4.
Although the VEGF treatment levels led to variableresults, the greatest number of FLK1+ VPCs was consist-
ently and statistically significant in cultures seeded at the
highest seeding density (Fig. 2a-b) while cells initially
seeded at 1,000 cells/cm2 generated significantly fewer
FLK1+ cells. Bright field microscopy revealed that after
three days, the 10,000 cells/cm2 seeding density remained
subconfluent (Fig. 2c).
Metabolic shift during density-dependent differentiation
To identify density-dependent changes in cellular metabol-
ism during differentiation, we measured metabolite abun-
dance within conditioned media using 1D 1H-NMR
spectroscopy. This exometabolome analysis provides in-
sights into metabolite utilization and secretion. A reduction
in metabolite abundance is consistent with cellular uptake
from our chemically defined induction media, whereas an
increase in abundance correlates with active production
and extracellular secretion. Of the metabolites in the differ-
entiation media profiled, only lactate exhibited an increase
in abundance. Cells seeded at a density of 10,000 cells/cm2
displayed a rapid increase in lactate production between
days 1 and 2, which then slowed between days 2 and 3
(Fig. 3a-b). Conversely, cells grown at a density of 1,000
cells/cm2 produce, on a per cell basis, comparatively more
lactate, and exhibit a significant increase in lactate abun-
dance between days 1 and 3 (9.0 vs 3.8; p-value < 0.001)
(Fig. 3a-b). The same trend is seen in metabolite utilization.
Cells grown at a density of 10,000 cells/cm2 exhibit higher
rates of metabolite utilization between day 1 and day 2, and
much lower utilization between days 2 and 3 (Fig. 3c-d). In
contrast, cells seeded at lower density increase their metab-
olite uptake over time, exhibiting their highest levels of
utilization between days 2 and 3 (Fig. 3c-d).
Differentiation correlates with increased cell size and
reduced proliferation
To determine whether the observed shift in metabolite
utilization coincides with a change in cellular proliferation,
we measured the number of live cells present for both
seeding densities following induction of differentiation.
Cells induced at a density of 10,000 cells/cm2 have a
higher proliferation rate between day 1 and day 2 (3.32 vs.
2.07; p-value < 0.001) and a lower proliferation rate be-
tween day 2 and day 3 (2.01 vs. 3.73; p-value < 0.001)
(Fig. 4a). In contrast, cells grown at low density continue
to increase their proliferation rate over the 3 days of in-
duction. Notably, while VPCs are not contact-inhibited,
cell cultures at all seeding densities remain subconfluent
after 3 days of culture (Fig. 1D) and continue to prolifer-
ate. A3-ESCs seeded at the highest density contained
fewer cells of a small diameter representative of ESC
size three days post induction compared with cells seeded
at lower density (5–6 μm, 26% vs 36%; p-value < 0.001).
Additionally, proportionately more cells of larger
Fig. 2 Higher seeding density yields higher expression of differentiation marker FLK1 (FLK1 = VEGFR = KDR, kinase insert domain receptor). The effect
of (a) seeding density, (b) vascular endothelial growth factor (VEGF) concentration, and induction time on the percentage of FLK1+ vascular progenitor
cells (VPCs) generated from embryonic stem cells (ESCs). An induction time of three days combined with a seeding density of 10,000 cells/cm2
resulted in high percentages of FLK1+ cells regardless of VEGF concentration. c Phase contrast images and flow cytometic cell scanning histograms of
FLK1 expression of ESCs induced on 50 ng/mL fibronectin with 20 ng/mL VEGF treatment. Upper panel shows time course following seeding densities
of 1,000 cells/cm2. Lower panel shows time course following seeding densities of 10,000 cells/cm2. By day 3 post induction, the majority of cells seeded
at 10,000 cells/cm2 exhibit FLK1 receptor expression. In contrast, cells initially seeded at 1,000 cells/cm2 exhibit less FLK1 receptor expression and
exhibit fewer cell clusters at day 3
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Fig. 3 Density-dependent shift of metabolic rate. 1D 1H-NMR spectroscopic exometabolome analysis of conditioned media from induced embry-
onic stem cells (ESCs) initially seeded at 1,000 cells/cm2 (blue) and 10,000 cells/cm2 (red). a By day 3, cells seeded at higher density reduce produc-
tion of lactate whereas cells initially seeded at low density continue to increase lactate production and exhibit a significantly higher fold increase
in lactate abundance between days 1 and 3 (9.0 vs 3.8; *** p-value < 0.001). b Fold change of lactate production relative to day 1. c Amino acid
uptake of valine, isoleucine, phenylalanine, and glutamine/glutamate (glx) significantly increases in the low density group after two days of induction
(*** p-value < 0.001). d Amino acid uptake plateaus between 2 and 3 days post induction in the higher density group. Fold change of amino acid up-
take relative to day 1
Fig. 4 Density-dependent shift of proliferation and cell diameter. a Proliferation rate significantly slows at day 3 in cells seeded at 10,000 cells/cm2
(red) but increases in cells seeded at 1,000 cells/cm2 (blue; fold increase of 2.1 vs 3.7; *** p-value < 0.001). b Higher density cells have a greater
percentage of cells with large diameter (9–10 μm, 19.6% vs 8.2%; *** p-value < 0.001) and fewer small diameter cells (5–6 μm, 26.1% vs 36.2%;
*** p-value < 0.001). c Flow cytometric cell scanning contour plot indicating 10,000 cells/cm2 seeding density results in a greater proportion of cells
exhibiting high forward scatter and FLK1 allophycocyanin conjugate (APC) positivity
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10,000 cells/cm2 compared with lower density (9–10 μm,
20% vs 8%; p-value < 0.001) (Fig. 4b). The forward scatter
measurements from fluorescence-activated cell sorting in
flow cytometry, another indication of cell size, show that
the early A3-ESCs are smaller compared with the larger
differentiated FLK1+ VPCs (Fig. 4c).
Differential gene expression of cell-to-cell signaling
molecules during density-dependent differentiation
In order to further investigate the density-dependent
signaling directing FLK1+ VPCs, a number of cell-to-cell
signaling molecules were examined using a targeted PCR
array. The expression pattern of cells seeded at densities
of 10,000 cells/cm2 or 1,000 cell/cm2 revealed significant
differential expression with p-values below 0.05 and a
fold change of 2.0 or higher (Fig. 5a). Gene expressionFig. 5 Differential gene expression analysis of density-dependent differentiati
a Gene expression analysis of embryonic stem cells (ESCs) as well as vascular
The logarithmic fold change of cells seeded at 10,000 cells/cm2 in comparison
processes. Gene symbols labeled with an asterisk * indicate significant differen
b Poor differentiation efficiency of embryonic stem cells seeded at low densit
embryonic stem cells at high density of 10,000 cells/cm2 results in expression
starting point for tissue engineering. d Enlarged diagram of cell-cell contact s
I. Cell-cell contacts mediate signals into nucleus. II. Transcriptional changes cre
regulators of adherens junctions and desmosomes. III. Switch of metabol
IV. Enforcement of new cell surface contacts. V. Propagation of differentiapattern included significant up-regulation of NOTCH1
(GeneBank: 4851), NOTCH4 (GeneBank: 4855), CDH4,
cadherin 4, retinal, R-cadherin (GeneBank: 1002), CDH5,
cadherin 5, vascular endothelium, VE-cadherin (GeneBank:
1003), DSG1B, desmoglein 1 (GeneBank: 1828), DSG2,
desmoglein 2 (GeneBank: 1829), PKP1, plakophilin 1
(GeneBank: 5317), CTNNA2, catenin cadherin-associated
protein alpha 2 (GeneBank: 1496), WAS, Wiskott-Aldrich
syndrome (GeneBank: 7454), and WASF1, WAS protein
family, member 1 (GeneBank: 8936) as well as significant
down-regulation of NOTCH3 (GeneBank: 4854), and
PKP2, plakophilin 2 (GeneBank: 5318).
Differential protein expression of cell-to-cell signaling
molecules during density-dependent differentiation
Protein level differences in cell-to-cell signaling molecule
expression were quantified by flow cytometry (Fig. 6).on identifies molecules related to cellular adhesion and vascular genesis.
progenitor cells (VPCs) seeded at density of 1,000 vs 10,000 cells/cm2.
to 1,000 cells/cm2 (LOG2(FC 10 K/1 K)) identifies density-depended
tial expression with p-values below 0.05. Schematic model compares:
y of 1,000 cells/cm2, where isolated cells eventually die off. c Seeding of
of differentiation markers of vascular progenitor cells, which are a potent
hows signaling processes and positive feedback enhancing differentiation:
ate positive feedback enforcing cell surface contacts and stimulating
ism from exponential, proliferative mode to differentiated phenotype.
tion state to neighboring cells
Fig. 6 Differential protein expression of cell adhesion molecules during density-dependent differentiation identifies molecules related to cellular
adhesion and formation of vascularization. Protein expression analysis of induced vascular progenitor cells (VPCs) derived from embryonic stem
cells (ESCs) comparing seeding densities of 1,000 vs 10,000 cells/cm2. Flow cytometric cell scanning plots of 100,000 events of differentiating
FLK1+ embryonic stem cells (a) seeded at low density of 1,000 cells/cm2 and (b) seeded at high density of 10,000 cells/cm2. The FLK1+ cells were gated
in quadrant 1 (Q1) for FLK1+/CDH2+CDH5−, in quadrant 2 (Q2) for FLK1+/CDH2+CDH5+, in quadrant 3 (Q3) for FLK1+/CDH2−CDH5−, and in quadrant 4
(Q4) for FLK1+/CDH2−CDH5+. Markers were quantified by fluorescence of FLK1 allophycocyanin conjugate (APC), CDH2 fluorescein isothiocyanate
(FITC) conjugate and CDH5 brilliant violet (BV) conjugate. c Fold change of FLK1+/CDH2+CDH5+ gated in Q2 with significant differential expression of
cells derived from seeding at densities of 1,000 vs 10,000 cells/cm2 indicated by asterisk * with p-value below 0.05
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10,000 cells/cm2 were stained and analyzed for FLK1,
CDH2 (cadherin 2, neuronal, N-cadherin, GeneBank: 1000)
and CDH5 expression. Importantly, the cell adhesion
molecule CDH5, VE-cadherin, is indicative of vascular
endothelial differentiation. The percentage of cells staining
positive for FLK1, CDH2, and CDH5, FLK+/CDH2+CDH5+,
quadrant 2, (Fig. 6a-b) was higher for cells originally seeded
at 10,000 cells/cm2 than those seeded at 1,000 cells/cm2
(1.51% vs 0.70%, p < 0.01) (Fig. 6c).
Discussion
The generation of FLK1+ VPCs from ESCs peaks on day
3, followed by a reduction in FLK1+ numbers (Fig. 2ab)
within the range of reported days (2–5) during mesoderm
induction from ESCs [15, 17, 22–25]. The other significant
variable in the efficient induction of VPCs was a high cell
seeding density (Fig. 2a-b), while VEGF treatment level
was not significant. The higher density and robustly differ-
entiating VPC cultures also correlated with reduced prolif-
eration rates and greater cell diameters, both indicative of
differentiation (Fig. 4). Although these cells are not con-
tact inhibited nor were they confluent cultures, hypoxia is
known to drive mesoderm commitment [26, 27] and
endothelial fate [19] from ESCs. To determine whether
hypoxia could drive ESC differentiation, we calculated the
molar fraction of oxygen at the cell surface of our high
density cell dishes cultures. Using our experimental cell
proliferation rates, estimated oxygen solubility in saline
solution, and oxygen consumption rates reported for both
ESCs = 27.5x10−18 [28] and ECs = 50x10−18 mol/cell/s
[20], it was determined that, although oxygen would be
reduced at higher cell seeding densities, none of the con-
ditions would generate a hypoxic environment (defined as
1-3% oxygen).Interestingly, VEGF treatment was not a determining or
statistically significant variable in directing VPC fate. A
large body of data implicates VEGF signaling in mesoderm
and endothelial cell fate and that the FLK1/VEGF receptor
is one of the key markers defining the angioblast cell
[12, 14, 29, 30]. However, since BMP4 signaling can also
activate the VEGF/VEGFR signaling [31, 32], it is sufficient
in the inductions shown. Moreover, the two distinct VEGF
binding domains in the fibronectin matrix [33] may
stabilize and protect autocrine VEGF production from
degradation [33], as well as, aid in cell presentation. The
presumptive requirement of VEGF treatment in chemically-
defined media for EC fate has been most rigorously exam-
ined using single cells cultured in collagen-type IV coated
96-well plates [12, 30, 34]. Without fibronectin matrix to
sequester and protect the VEGF generated by the cells, one
might expect that VEGF treatment would be required in
these cultures. However, our results suggest that the
utilization of fibronectin matrix mitigates the need for VEGF
supplementation in VPC induction cultures.
Differential gene expression array analysis identified a
number of cell-to-cell signaling molecules that were up-
regulated in the higher density cultures containing more
VPCs. Differential expression of cell surface receptors,
desmosome, catenins, and cytoskeleton regulators could
be required for, or facilitate, the density-dependent
differentiation of ESCs (Fig. 5b-d). Vascular cells take
advantage of many different cell adhesion contacts
demonstrated by the global up-regulation of cadherins,
desmosomal and desmoglein components. Since cell sur-
face molecules have the ability to communicate extracel-
lular changes into the cytosol, such as contact formation
with neighboring cells, the gene expression data suggests
a positive feedback reinforcing cellular contacts (Fig. 5d).
Initial cell-cell contacts mediate signals into the nucleus,
Singh et al. Cell Communication and Signaling  (2017) 15:44 Page 9 of 12where transcriptional changes create positive feedback
promoting and strengthening cell surface contacts and
stimulating regulators of adherens junctions and desmo-
somes. Positive feedback circuits have the ability to cre-
ate threshold densities for successful differentiation.
Once established and supported by the cell type specific
cell surface contacts molecules, signals of differentiation
can lead to lineage committed cell fates and organized
tissue formation.
Amongst genes exhibiting the strongest change in
the context of seeding density-dependent differenti-
ation of VPCs were the cytoskeleton regulators WAS
and CTNNA2. The expression pattern for both genes
is unaffected in the lower density cohort but was con-
sistently up-regulated in the higher density cohort.
Wiskott-Aldrich syndrome protein (WASP) is a key
regulator of endothelial cell-cell junctions and cyto-
skeleton dynamics and helps form and maintain the
integrity and function of EC monolayers [35]. More-
over, WASP organizes actin and vascular epithelium-
cadherins at EC junctions, and hence is vital for the
assembly of vascular structures [35–37]. Importantly,
along with FLK1 expression, WAS and CDH5 are also
indicators of vascular differentiation [8]. Other studies
have identified members of the E-twenty six (ETS)
transcription factor family associating with FLK1 and
CDH5 promoters in vascular epithelia to regulate vascular
specification from primitive mesoderm [8–10, 38]. In
murine and amphibian model organisms, plakophilins
have been found localized to the nucleus of ESCs
and form complexes with members of the ETS family
of transcription factors to direct development related
gene transcription events [39].
Similar to PKP1, CTNNA1, catenin cadherin-associated
protein, alpha 1 (GeneBank: 1495) and AJAP1, adherens
junctions associated protein 1 (GeneBank: 55966) expres-
sion levels are correlated with advancing tumor stage and
inversely related to cell proliferation [32, 40, 41]. While
CTNNA2 has been found as hub for extracellular matrix
organization, loss of CTNNA1 is exhibited by multiple
cancer types, and restoration of CTNNA1 expression in
acute myeloid leukemia cells led to lower proliferation
[27, 40]. Additionally CTNNA1 regulates differentiation
events in the developing nervous system by maintaining
beta-catenin signaling [42]. It is possible that the higher
levels of PKP1 and CTNNA1 seen in the 10,000 cells/cm2
density group causes these cells to slow their prolife-
ration in favor of differentiation and growth. The
regulation of desmosomal assembly by DSG1B, DSG2,
and PKP1 not only enforces cell surface adhesion
contacts between ECs but also regulates the cell
signaling events in the cytoplasm and nucleus. DSG2
regulates actin assembly in ECs and affects prolifera-
tion via modulation of EGFR signaling [43, 44]. PKP1associates with eukaryotic translation initiation factor
4A1 to stimulate protein translation [45] and loss of
PKP1 is linked to prostate cancer proliferation [46].
Nuclear PKP1 complexes with catenin and is found
bound to single stranded DNA [47]. PKP2, which is
more abundant in the lower density group, binds to
catenin and complexes with the RNA polymerase III
holoenzyme [48].
The cadherin family uniformly responds to density-
dependent differentiation [36, 37]. All cadherins
assayed show up-regulation in the higher density co-
hort. CDH4 shows the highest density-dependent
fold-change of the cadherin family. In addition to
significant density-dependent up-regulation, vascular
endothelial CDH5 is also significantly different be-
tween undifferentiated and induced ESCs. Of the
desmosomal, desmocollin, and desmoglein compo-
nents, DSG1B, DSG2, and PKP1 stand out as positive
responders to density-dependent differentiation sup-
porting formation of cell surface adhesion contacts in
endothelial formation. For the majority of cell surface,
cell junction and desmosomal components, a global
increase in gene expression in response to density-
dependent seeding is observed.
Among the differentiation and density-dependent
effects on gene expression, perhaps the most pro-
found is differential expression of the NOTCH recep-
tor family. NOTCH signaling is a highly conserved
intercellular signaling mechanism essential for proper
cell fate choices during development [49]. Both
NOTCH1 and NOTCH4 have both been implicated
in vascular morphogenesis [50]. Moreover, NOTCH1
is found expressed in both endothelial and hematopoietic
progenitor cells [51], while NOTCH4 is expressed in
ECs, but not in hematopoietic progenitor cells [50].
NOTCH3 signaling is highest in late stage smooth
muscle cell differentiation [52] and neural differentiation
[53]. In the high cell density cultures, NOTCH1 and
NOTCH4 were significantly up-regulated, while NOTCH3
is significantly down-regulated at induction conditions
of 10,000 cells/cm2 compared with the lower density
cultures.
It is expected that differential expression of NOTCH
components within ESCs seeded at higher density is, at
least indirectly, responsible for the shift in metabolite
utilization observed during the differentiation process.
Specifically, NOTCH signaling has recently been linked
to the regulation of cellular metabolism [54, 55], indu-
cing glutamate uptake during the terminal differentiation
of astrocytes [54]. Furthermore, NOTCH inhibition in
glioma stem cells led to reductions in intracellular glu-
tamate and glutamine, and increased lactate and threo-
nine [55]. In the same study, it was noted that NOTCH
blockade modulated the expression of multiple genes
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and several glutamate transporters [55]. Tight regulation
of glutaminase activity and glutamate metabolism are
vital features of both stem cell function and tumor sur-
vival [11, 30, 44]. Interestingly, glutamine metabolism
also regulates chromatin structure and pluripotency
related transcription factors, such as OCT4, and
therefore may play a pivotal role in vascular development
[20]. Additional studies examining the role of cell-cell
signaling components, particularly NOTCH, in the
regulation of glutaminergic and other metabolic pathways
could help optimize strategies for ESC differentiation and
understand NOTCH-mediated cancer progression.
An increase in cell size correlating with stem cell
differentiation is intimately coupled to loss of “stem-
ness”. Moreover, larger cells proliferate more slowly
compared to smaller cells [56]. While in cancer cells,
a positive feedback is used to rapidly ramp up a
distinct metabolic program [57], cellular differenti-
ation is accompanied by a switch in metabolism from
an exponential proliferative mode into a differentiated
phenotype. During the time course of differentiation,
ESCs start out as small, rapidly dividing cells, but
rapidly shift away from exhaustive glycolysis and high
metabolite consumption to a reduced metabolic de-
mand per cell. This observed switch in metabolism
also supports the changing demands of larger, more
differentiated VPCs. Our data shows that the gene
expression program of these differentiating ESCs also
dynamically responds to the culture conditions at
higher cellular density, and actively reinforces cell
surface signaling components leading to up-regulation
of genes associated with VPC fate. This strengthening
of cellular communication may help regulate the
concurrent switch of metabolism from an exponential,
proliferative mode to a differentiated, growth permis-
sive phenotype.Conclusions
In summary, we have identified a density-dependent
metabolic shift correlating with increased differenti-
ation of VPCs from ESCs. This density-dependent
differentiation model is associated with reduced cellu-
lar metabolism, highlighted by a decrease in exhaust-
ive glycolysis, by a decrease in proliferation, and by
an increase in cell size. Concomitant is enhanced
expression of cell-cell signaling components, including
those known to regulate the differentiation and me-
tabolism of stem cells via density-sensing positive
feedback circuits. In the future, efficient tissue engineering
approaches may take advantage of such density-
dependent switches and control crosstalk between cell-
cell signaling and cellular metabolism.Abbreviations
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